bioAffinity Technologies (BIAF) Return on Equity: 2022-2025
Historic Return on Equity for bioAffinity Technologies (BIAF) over the last 3 years, with Sep 2025 value amounting to -4.36%.
- bioAffinity Technologies' Return on Equity fell 178.00% to -4.36% in Q3 2025 from the same period last year, while for Sep 2025 it was -4.36%, marking a year-over-year decrease of 178.00%. This contributed to the annual value of -2.42% for FY2024, which is 143.00% down from last year.
- bioAffinity Technologies' Return on Equity amounted to -4.36% in Q3 2025, which was down 112.98% from 33.55% recorded in Q2 2025.
- In the past 5 years, bioAffinity Technologies' Return on Equity registered a high of 33.55% during Q2 2025, and its lowest value of -4.82% during Q1 2025.
- In the last 3 years, bioAffinity Technologies' Return on Equity had a median value of -1.65% in 2024 and averaged 0.98%.
- Examining YoY changes over the last 5 years, bioAffinity Technologies' Return on Equity showed a top increase of 3,557bps in 2025 and a maximum decrease of 316bps in 2025.
- Quarterly analysis of 4 years shows bioAffinity Technologies' Return on Equity stood at -0.69% in 2022, then crashed by 65bps to -1.34% in 2023, then plummeted by 182bps to -3.16% in 2024, then tumbled by 178bps to -4.36% in 2025.
- Its Return on Equity was -4.36% in Q3 2025, compared to 33.55% in Q2 2025 and -4.82% in Q1 2025.